Atherosclerosis Supplements (AS)

Atherosclerosis Supplements is a series of scientific supplement issues published by Elsevier Ireland Ltd that extends the scope of the main Atherosclerosis journal by compiling additional research, conference proceedings, and thematic collections relevant to atherosclerosis and cardiovascular science. It began publication around 2000 and carries print ISSN 1567-5688 and electronic ISSN 1878-5050. Unlike typical periodicals, the supplement does not adhere to a strict monthly or quarterly schedule but appears in conjunction with specialized events, symposia, or thematic compilations addressing emerging and focused areas within cardiovascular research. Its content spans a broad range of topics connected to atherosclerotic disease — including lipid metabolism, vascular biology, inflammation, and clinical risk factors such as diabetes and hypertension — making it a valuable resource for cardiovascular scientists and clinicians engaged in cutting-edge studies. Although no specific Editor-in-Chief is listed solely for the supplement series in public bibliographic records, its editorial oversight is integrated with the main Atherosclerosis editorial team. As part of Elsevier’s portfolio, Atherosclerosis Supplements contributes to disseminating supplemental cardiovascular research that complements mainstream journal issues, aiding ongoing scientific dialogue in the field.

Atherosclerosis Supplements (AS) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cardiology and Cardiovascular Medicine, General Medicine, Internal Medicine, lipid metabolism, inflammation, hypertension, conference proceedings or supplemental collections arising from meetings in the field, clinical and experimental studies , Online or Print , Irregular Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1567-5688, E-ISSN: 1878-5050, Established: 2000,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE